TrialBritish journal of cancer2021

Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer.

Frances Willenbrock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.